Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.

AIDS (London, England) - 16 Jan 2010

McMahon Moira A, Siliciano Janet D, Kohli Rahul M, Siliciano Robert F

Abstract excerpt

Trials of acyclovir for herpes simplex virus 2 infection in herpes simplex virus 2/HIV-1 coinfected patients not on antiretroviral therapy demonstrated a decrease in herpes simplex virus 2 and HIV-1 replication. Recent studies indicated that acyclovir has direct anti-HIV-1 activity and can select...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acyclovir
Share to Anti-HIV Agents
Share to Guanine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Herpes Genitalis

Share to Herpesvirus 2, Human

Share to HIV Reverse Transcriptase

Share to Viral Load

Share to Zidovudine

Source

Identifiers

PMID: 20009920
DOI: 10.1097/QAD.0b013e32833424e5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20009920-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.PMID 20009920Read ↗

The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.Semantic proximity Read ↗

Herpes Simplex Virus Type 2 Suppressive Therapy with Acyclovir or Valacyclovir Does Not Select for Specific HIV-1 Resistance in HIV-1/HSV-2 Dually Infected PersonsSemantic proximity Read ↗

Acyclovir Is Activated into a HIV-1 Reverse Transcriptase Inhibitor in Herpesvirus-Infected Human TissuesSemantic proximity Read ↗

Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.Semantic proximity Read ↗

Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.Semantic proximity Read ↗

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.Semantic proximity Read ↗

Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.Semantic proximity Read ↗

Acyclovir-resistant, pathogenic herpesviruses.Semantic proximity Read ↗

Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.Semantic proximity Read ↗

Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.Semantic proximity Read ↗

Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.Semantic proximity Read ↗

Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.